Kaurenoic acid nanocarriers regulates cytokine production and inhibit breast cancer cell migration

Sung, 2021, Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660

Perret, 2008, New pharmacological strategies against metastatic spread, Fundam. Clin. Pharmacol., 22, 465, 10.1111/j.1472-8206.2008.00614.x

Schmadeka, 2014, Triple-negative breast carcinoma: current and emerging concepts, Am. J. Clin. Pathol., 141, 462, 10.1309/AJCPQN8GZ8SILKGN

Mendonza, 2010, Modeling metastasis biology and therapy in real time in the mouse lung, J. Clin. Invest., 120, 2979, 10.1172/JCI40252

Eckhardt, 2005, Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix, Mol. Cancer Res., 3, 1, 10.1158/1541-7786.1.3.1

Bartsch, 2003, Matrix metalloproteinase expression in breast cancer, J. Surg. Res., 110, 383, 10.1016/S0022-4804(03)00007-6

Bonapace, 2014, Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis, Nature, 515, 130, 10.1038/nature13862

Cheng, 2021, Review on the development and applications of medicinal plant genomes, Front. Plant Sci., 12, 10.3389/fpls.2021.791219

Damasceno, 2019, Investigation of safety profile of four Copaifera species and of Kaurenoic acid by Salmonella/microsome test, Evid. Based Complement. Alternat. Med., 2019, 7631531, 10.1155/2019/7631531

Choi, 2011, Inhibitory effects of kaurenoic acid from Aralia continentalis on LPS-induced inflammatory response in RAW264.7 macrophages, Phytomedicine, 18, 677, 10.1016/j.phymed.2010.11.010

Kian, 2018, Trypanocidal activity of copaiba oil and kaurenoic acid does not depend on macrophage killing machinery, Biomed. Pharmacother., 103, 1294, 10.1016/j.biopha.2018.04.164

Macri, 2015, Immunomodulatory and antioxidant properties of Kaurenoic acid on macrophages of BALB/c in vitro, Am. J. Immunol., 10, 183, 10.3844/ajisp.2014.183.188

Miranda, 2015, Kaurenoic acid possesses leishmanicidal activity by triggering a NLRP12/IL-1 β/cNOS/NO pathway, Mediat. Inflamm., 2015, 1, 10.1155/2015/392918

Cardoso, 2017, Effect of diterpenoid kaurenoic acid on genotoxicity and cell cycle progression in gastric cancer cell lines, Biomed. Pharmacother., 89, 772, 10.1016/j.biopha.2017.02.085

Cavalcanti, 2009, Kauren-19-oic acid induces DNA damage followed by apoptosis in human leukemia cells, J. Appl. Toxicol., 29, 560, 10.1002/jat.1439

Guidoti, 2019, Kaurenoic acid from Annona squamosa L. exhibits antiproliferative effect on human tumor cell lines and induces apoptosis in Aspergillus nidulans, Fitos, 13, 122, 10.17648/2446-4775.2019.716

Peria, 2010, Kaurenoic acid antitumor activity in breast cancer cells, J. Clin. Oncol., 28, e13641, 10.1200/jco.2010.28.15_suppl.e13641

Rocha, 2019, Effect of the kaurenoic acid on genotoxicity and cell cycle progression in cervical cancer cells lines, Toxicol. in Vitro, 57, 126, 10.1016/j.tiv.2019.02.022

Sung, 2008, Chemokines Cytokines Interleukins, 111, 4880

Mussbacher, 2019, Cell type-specific roles of NF-κB linking inflammation and thrombosis, Front. Immunol., 10, 85, 10.3389/fimmu.2019.00085

Perrot-Applanat, 2011, Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies, PLoS One, 6, 10.1371/journal.pone.0021589

Zhao, 2021, Inflammation and tumor progression: signaling pathways and targeted intervention, Signal Transduct. Target. Ther., 6, 263, 10.1038/s41392-021-00658-5

Matos, 2018, Pharmacokinetic profile and oral bioavailability of Kaurenoic acid from Copaifera spp. in rats, Fitoterapia, 128, 142, 10.1016/j.fitote.2018.05.013

Ghasemiyeh, 2018, Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages, Res. Pharm. Sci., 13, 288, 10.4103/1735-5362.235156

Santos, 2018, Setting precise temperature for triggered release from nanostructured lipid carriers, IFAC-PapersOnLine, 51, 1, 10.1016/j.ifacol.2018.11.598

Clemente, 2009, Fatty acid profile of “bottled butter fat” produced in the region of Salinas, Minas Gerais, Ciência Agrotecnol., 33, 1615, 10.1590/S1413-70542009000600022

Soldati, 2018, Controlled release of resveratrol from lipid nanoparticles improves antioxidant effect, IFAC-PapersOnLine, 51, 16, 10.1016/j.ifacol.2018.11.600

Xu, 2009, The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma, Biomaterials, 30, 226, 10.1016/j.biomaterials.2008.09.014

Xie, 2017, The effect of shape on cellular uptake of gold nanoparticles in the forms of stars, rods, and triangles, Sci. Rep., 7, 3827, 10.1038/s41598-017-04229-z

Beg, 2017, Novel surface-engineered solid lipid nanoparticles of rosuvastatin calcium for low-density lipoprotein-receptor targeting: a quality by design-driven perspective, Nanomedicine (London, England), 12, 333, 10.2217/nnm-2016-0336

Piazzini, 2019, Solid lipid nanoparticles and chitosan-coated solid lipid nanoparticles as promising tool for Silybin delivery: formulation, characterization, and in vitro evaluation, Curr. Drug Deliv., 16, 142, 10.2174/1567201815666181008153602

Patel, 2019, Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies, Artif. Cells Nanomed. Biotechnol., 47, 144, 10.1080/21691401.2018.1546186

Shi, 2014, Determination of rhodamine B in lipsticks by high performance liquid chromatography after extraction with AOT reversed micelles, Anal. Methods, 6, 8627, 10.1039/C4AY01740D

Silva, 2021, Licochalcone A-loaded solid lipid nanoparticles improve antischistosomal activity in vitro and in vivo, Nanomedicine, 16, 1641, 10.2217/nnm-2021-0146

Limame, 2012, Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays, PLoS One, 7, 10.1371/journal.pone.0046536

Siafaka, 2016, Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses, Int. J. Mol. Sci., 17, 1440, 10.3390/ijms17091440

Battaglia, 2012, Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery, Expert Opin. Drug Deliv., 9, 497, 10.1517/17425247.2012.673278

Soddu, 2014, The effect of formulative parameters on the size and physical stability of SLN based on “green” components, Pharm. Dev. Technol., 21, 98, 10.3109/10837450.2014.971376

Kalyane, 2019, Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer, Mater. Sci. Eng. C Mater. Biol. Appl., 98, 1252, 10.1016/j.msec.2019.01.066

Subhan, 2021, Recent advances in tumor targeting via EPR effect for cancer treatment, J. Personal. Med., 11, 571, 10.3390/jpm11060571

Almeida, 2021, Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine, Chem. Soc. Rev., 50, 5397, 10.1039/D0CS01127D

Zhu, 2013, Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration, J. Pharm. Pharmacol., 65, 1107, 10.1111/jphp.12074

Arana, 2019, Solid lipid nanoparticles surface modification modulates cell internalization and improves chemotoxic treatment in an oral carcinoma cell line, Nanomaterials (Basel, Switzerland), 9, 464, 10.3390/nano9030464

Chen, 2015, The therapeutic effect of methotrexate-conjugated Pluronic-based polymeric micelles on the folate receptor-rich tumors treatment, Int. J. Nanomedicine, 10, 4043, 10.2147/IJN.S79045

Batista, 2007, Synthesis and trypanocidal activity of ent-kaurane glycosides, Bioorg. Med. Chem., 15, 381, 10.1016/j.bmc.2006.09.048

Santos, 2013, Antileishmanial activity of diterpene acids in copaiba oil, Mem. Inst. Oswaldo Cruz, 108, 59, 10.1590/S0074-02762013000100010

Vargas, 2015, Biological activities and cytotoxicity of diterpenes from Copaifera spp, Oleoresins. Molecules, 20, 6194, 10.3390/molecules20046194

Dutta, 2002, Peptide immunomodulators versus infection; an analysis, Immunol. Lett., 83, 153, 10.1016/S0165-2478(02)00066-4

Bouabe, 2012, Cytokine reporter mice: the special case of IL-10, Scand. J. Immunol., 75, 553, 10.1111/j.1365-3083.2012.02695.x

Guijarro-Muñoz, 2014, Lipopolysaccharide activates toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes, J. Biol. Chem., 289, 2457, 10.1074/jbc.M113.521161

Kawasaki, 2014, Toll-like receptor signaling pathways, Front. Immunol., 5, 461, 10.3389/fimmu.2014.00461

Cárdeno, 2014, Extra virgin olive oil polyphenolic extracts downregulate inflammatory responses in LPS-activated murine peritoneal macrophages suppressing NFκB and MAPK signalling pathways, Food Funct., 5, 1270, 10.1039/C4FO00014E

Soria, 2011, Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition, BMC Cancer, 11, 130, 10.1186/1471-2407-11-130

Esquivel-Velázquez, 2015, The role of cytokines in breast cancer development and progression, J. Interf. Cytokine Res., 35, 1, 10.1089/jir.2014.0026

Holen, 2016, IL-1 drives breast cancer growth and bone metastasis in vivo, Oncotarget, 7, 75571, 10.18632/oncotarget.12289

Fisher, 2014, The two faces of IL-6 in the tumor microenvironment, Semin. Immunol., 26, 38, 10.1016/j.smim.2014.01.008

Bauer, 2017, Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells, PLoS One, 12, 10.1371/journal.pone.0175558

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013